Human immunodeficiency virus reverse transcriptase and protease sequence database

被引:705
作者
Rhee, SY [1 ]
Gonzales, MJ [1 ]
Kantor, R [1 ]
Betts, BJ [1 ]
Ravela, J [1 ]
Shafer, RW [1 ]
机构
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
关键词
D O I
10.1093/nar/gkg100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV reverse transcriptase and protease sequence database is an on-line relational database that catalogues evolutionary and drug-related sequence variation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, the molecular targets of antiretroviral therapy (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences, including submissions to GenBank, sequences published in journal articles and sequences of HIV isolates from persons participating in clinical trials. Sequences are linked to data about the source of the sequence, the antiretroviral drug treatment history of the person from whom the sequence was obtained and the results of in vitro drug susceptibility testing. Sequence data on two new molecular targets of HIV drug therapy-gp41 (cell fusion) and integrase will be added to the database in 2003.
引用
收藏
页码:298 / 303
页数:6
相关论文
共 13 条
  • [1] Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype
    Beerenwinkel, N
    Schmidt, B
    Walter, H
    Kaiser, R
    Lengauer, T
    Hoffmann, D
    Korn, K
    Selbig, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 8271 - 8276
  • [2] Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes
    Grobler, JA
    Stillmock, K
    Hu, BH
    Witmer, M
    Felock, P
    Espeseth, AS
    Wolfe, A
    Egbertson, M
    Bourgeois, M
    Melamed, J
    Wai, JS
    Young, S
    Vacca, J
    Hazuda, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6661 - 6666
  • [3] Hazuda D, 2002, ANTIVIR THER, V7, pS3
  • [4] Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. -: J Antimicrob Chemother 1998; 42:269-270
    Vahaboglu, H
    Saribas, S
    Akbal, H
    Ozturk, R
    Yucel, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) : 269 - 270
  • [5] Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel
    Hirsch, MS
    Brun-Vézinet, F
    D'Aquila, RT
    Hammer, SM
    Johnson, VA
    Kuritzkes, DR
    Loveday, C
    Mellors, JW
    Clotet, B
    Conway, B
    Demeter, LM
    Vella, S
    Jacobsen, DM
    Richman, DD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18): : 2417 - 2426
  • [6] Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs
    Kantor, R
    Machekano, R
    Gonzales, MJ
    Dupnik, K
    Schapiro, JM
    Shafer, RW
    [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (01) : 296 - 299
  • [7] The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults
    Kilby, JM
    Lalezari, JP
    Eron, JJ
    Carlson, M
    Cohen, C
    Arduino, RC
    Goodgame, JC
    Gallant, JE
    Volberding, P
    Murphy, RL
    Valentine, F
    Saag, MS
    Nelson, EL
    Sista, PR
    Dusek, A
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (10) : 685 - 693
  • [8] Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
    Kilby, JM
    Hopkins, S
    Venetta, TM
    DiMassimo, B
    Cloud, GA
    Lee, JY
    Alldredge, L
    Hunter, E
    Lambert, D
    Bolognesi, D
    Mathews, T
    Johnson, MR
    Nowak, MA
    Shaw, GM
    Saag, MS
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1302 - 1307
  • [9] A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
    Petropoulos, CJ
    Parkin, NT
    Limoli, KL
    Lie, YS
    Wrin, T
    Huang, W
    Tian, H
    Smith, D
    Winslow, GA
    Capon, DJ
    Whitcomb, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 920 - 928
  • [10] Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
    Shafer, RW
    Jung, DR
    Betts, BJ
    [J]. NATURE MEDICINE, 2000, 6 (11) : 1290 - 1292